earnings
NU
NASDAQ · NUWE
Nuwellis, Inc.
Healthcare · Medical - Devices
$1.19
Down-$0.07 (-5.56%)
Updated Aug 19, 2026, 8:29 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.25M
- P/E ratio
- -0.03
- Dividend yield
- 0.00%
- 52-week range
- $1.22 – $235.20
- Volume
- 418.41K
- Avg. volume
- 166.14K
Price performance
NUWE price history
1M range · 21 trading sessions · Daily adjusted prices
NUWE closed at $1.19 after 21 trading sessions, down 58.25% for the selected period.
- Last close
- $1.19
- Period change
- -58.25%
- Period low
- $1.19
- Period high
- $4.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 18, 2026 | $1.25 | $1.295 | $1.15 | $1.19 | 418.41K |
| Aug 17, 2026 | $1.30 | $1.30 | $1.224 | $1.26 | 376.07K |
| Aug 14, 2026 | $1.32 | $1.37 | $1.30 | $1.31 | 291.84K |
| Aug 13, 2026 | $1.38 | $1.3902 | $1.25 | $1.30 | 710.64K |
| Aug 12, 2026 | $1.51 | $1.51 | $1.39 | $1.41 | 415.59K |
| Aug 11, 2026 | $1.43 | $1.55 | $1.4237 | $1.48 | 553.37K |
| Aug 10, 2026 | $1.41 | $1.49 | $1.41 | $1.42 | 618.81K |
| Aug 7, 2026 | $1.63 | $1.63 | $1.46 | $1.49 | 650.42K |
| Aug 6, 2026 | $1.70 | $1.80 | $1.6209 | $1.63 | 558.85K |
| Aug 5, 2026 | $1.79 | $1.85 | $1.63 | $1.71 | 1.1M |
| Aug 4, 2026 | $2.13 | $2.43 | $1.75 | $1.88 | 35.73M |
| Aug 3, 2026 | $1.67 | $1.76 | $1.3449 | $1.61 | 1.7M |
| Jul 31, 2026 | $1.74 | $1.93 | $1.61 | $1.74 | 6.87M |
| Jul 30, 2026 | $5.14 | $6.3999 | $3.70 | $4.45 | 117.94M |
| Jul 29, 2026 | $1.92 | $1.955 | $1.865 | $1.89 | 11.68M |
| Jul 28, 2026 | $1.935 | $1.9526 | $1.83 | $1.93 | 60.03K |
| Jul 27, 2026 | $2.00 | $2.02 | $1.85 | $1.99 | 78.87K |
| Jul 24, 2026 | $2.20 | $2.35 | $1.95 | $2.05 | 154.6K |
| Jul 23, 2026 | $2.63 | $2.63 | $2.06 | $2.20 | 362.46K |
| Jul 22, 2026 | $2.89 | $2.95 | $2.82 | $2.85 | 29.96K |
| Jul 21, 2026 | $2.99 | $2.99 | $2.7971 | $2.85 | 54.68K |
Latest NUWE news
The latest Smart Investors Daily articles mentioning NUWE.
Stock researchCompany · Financials
Loading stock research…